- Home
- MRM
as 07-26-2024 4:00pm EST
MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.
| Founded: | 2000 | Country: | Japan |
| Employees: | N/A | City: | N/A |
| Market Cap: | 18.5M | IPO Year: | 2020 |
| Target Price: | N/A | AVG Volume (30 days): | 2.9K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.15 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.40 - $6.90 | Next Earning Date: | 12-30-2022 |
| Revenue: | $48,151,925 | Revenue Growth: | 26.21% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest MEDIROM Healthcare Technologies Inc. News
MRM Breaking Stock News: Dive into MRM Ticker-Specific Updates for Smart Investing
GlobeNewswire
4 days ago
MEDIROM Healthcare Technologies Announces Business Transfer from Y’s, Inc.
GlobeNewswire
16 days ago
MEDIROM Healthcare Technologies Announces Acquisition of Japan Gene Medicine Corporation
GlobeNewswire
25 days ago
The first JAPAN IR Event 2024 was held at Nasdaq's U.S. headquarters
GlobeNewswire
a month ago
MEDIROM Healthcare Technologies Inc. Announces Financial Results for Fiscal Year 2023
CNW Group
2 months ago
Lotto 6/49 - $64 million up for grabs in the next draw!
Simply Wall St.
2 months ago
Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture
AFP
2 months ago
Seoul says it will resume loudspeaker propaganda against North
Simply Wall St.
2 months ago
It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend
Compare MRM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MRM MEDIROM Healthcare Technologies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.